Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

1st Quarter Results

15 Jun 2021 13:30

RNS Number : 9761B
British Smaller Companies VCT2 Plc
15 June 2021
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2021

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2021. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company's Total Return at 31 March 2021 was 126.8 pence per ordinary share, representing an increase of 1.8 pence per ordinary share over the Total Return of 125.0 pence per ordinary share as at 31 December 2020.

The fundraising in the quarter was fully subscribed and raised net proceeds of £6.8 million.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

31 December 2020

Increase in Value

Share issues including DRIS / buyback of shares

Dividends

Movement

In Period

31 March 2021

Net Assets (£m)

70.9

2.5

6.4

(1.9)

7.0

77.9

NAV per share (PPS)

55.0p

1.9p

(0.1p)

(1.5p)

0.3p

55.3p

Cumulative dividends paid (PPS)

70.0p

-

-

1.5p

1.5p

71.5p

Total Return (PPS)

125.0p

1.9p

(0.1p)

-

1.8p

126.8p

Shares in issue

128,956,091

-

12,011,378

-

12,011,378

140,967,469

The unaudited NAV per ordinary share increased from 55.0 pence per share to 56.9 pence per share, equivalent to 3.5 per cent in the period. Of this increase 1.5 pence per ordinary share was paid as an interim dividend on 5 March 2021, taking cumulative dividends paid at 31 March 2021 to 71.5 pence per ordinary share (31 December 2020: 70.0 pence per ordinary share). The resultant Net Asset Value at the end of the period is 55.3 pence per share.

The Company's Total Return over five years is 23.9 per cent.

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 December 2020

70.9

55.0

Increase in portfolio value

2.8

2.1

Net operating costs

(0.3)

(0.2)

Issue/buy-back of shares

6.4

(0.1)

8.9

1.8

NAV before payment of dividend

79.8

55.8

Dividend paid

(1.9)

(1.5)

NAV at 31 March 2021

77.9

55.3

Dividends and shares in issue

Following the payment of the interim dividend of 1.5 pence per share on 5 March 2021 the Company issued 742,805 ordinary shares under the DRIS.

The Company issued 12,756,951 ordinary shares on 11 March 2021 following the closure of the non-prospectus offer.

On 25 March 2021 the Company purchased 1,488,378 ordinary shares of 10 pence each at a price of 51.33 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 March 2021 was 140,967,469 (31 December 2020: 128,956,091). In addition, at 31 March 2021 the Company held 13,864,815 ordinary shares in treasury (31 December 2020: 12,376,437).

Investments

The investment portfolio at 31 March 2021 comprised:

Valuation

£000

Valuation as a % of net assets

Matillion Limited

14,053

18.0%

Intelligent Office UK Limited

3,132

4.0%

Springboard Research Holdings Limited

2,787

3.6%

KeTech Enterprises Limited

2,725

3.5%

Unbiased EC1 Limited

2,684

3.4%

Elucidat Limited

2,389

3.1%

ACC Aviation Group Limited

2,206

2.8%

Arcus Global Limited

2,096

2.7%

Deep-Secure Limited

2,062

2.7%

Force24 Ltd

1,934

2.5%

36,068

46.3%

Other investments

17,710

22.7%

Total investments

53,778

69.0%

Investments made prior to the November 2015 Budget represented 32 per cent of the value of the unquoted portfolio at 31 March 2021.

Following the period end three follow-on investments totalling £1.4 million have been completed.

Portfolio performance

Over the quarter to 31 March 2021 the aggregate portfolio valuation has increased by £2.8 million.

The Company has exchanged contracts for the sale of its shareholding in Deep-Secure Ltd. The transaction is subject to regulatory review and customary closing conditions and is expected to close in or before August 2021. If the transaction completes it would result in an uplift in the Company's unaudited NAV per ordinary share as at 31 March 2021 of 0.9 pence per ordinary share, an increase of 1.6 per cent.

Shareholder relations

Your Company will be holding an on-line version of the investor workshop on 25 June 2021, details of which have been communicated to shareholders.

 

Outlook

This year's lockdown seems to have had less impact on the economy than those in 2020. The demand for capital from the UK's small businesses shows no signs of slowing down and this should see an increasing numbers of investment opportunities through the rest of the year.

Your Board is therefore reviewing its plans for fundraising and intends to raise further capital later this year and will be announcing more details in due course.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

15 June 2021

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGPUPGQUPGGPA
Date   Source Headline
6th May 20267:00 amRNSDividend Declaration
20th Apr 202610:01 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:12 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNSAnnual Financial Report
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:31 amRNSDirector/PDMR Shareholding
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSInterim Management Statement
20th Nov 20259:00 amRNSOffer Update
31st Oct 202510:01 amRNSPayment of dividend and issue of Equity
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSHalf-year Report
22nd Aug 202510:45 amRNSNew combined offer for subscription
24th Jun 20257:00 amRNSTransaction in Own Shares
23rd Jun 202510:20 amRNSPayment of Dividend and Issue of Equity
13th Jun 20251:30 pmRNSInterim Management Statement
12th Jun 202510:46 amRNSResult of AGM
13th May 202512:54 pmRNSDividend Declaration
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:15 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNSAnnual Financial Report
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:21 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
17th Dec 20242:13 pmRNSNominal Capital Reduction
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:08 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNS3rd Quarter Results
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
12th Nov 20241:52 pmRNSResult of General Meeting
1st Nov 202411:04 amRNSPayment of Dividend and Allotment of Shares
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.